IREN Ltd
IREN
Bitdeer Technologies
BTDR
Mawson Infrastructure
MIGI
TeraWulf
WULF
Abits
ABTS
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.